Ispire Technology Inc. (NASDAQ: ISPR) reported its first quarter financial results on Tuesday, revealing a 59.1% year-over-year increase in revenue to $42.9 million in the three months ended Sept. 30, 2023.
Cannabis vaping products contributed $17.3 million to revenue during the fiscal first quarter of 2024, up by 116.8% year-over-year, while tobacco vaping products contributed $25.5 million, representing a 34.8% year-over-year increase.
"We remain confident in our ability to maintain our position as the leading premier precision dosing technology company as we've …